AU Patent

AU2002347182A1 — Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases

Assigned to Relief Therapeutics International SA · Expires 2003-06-30 · 23y expired

What this patent protects

Patent listed against lumasiran-sodium.

Drugs covered by this patent

lumasiran-sodium (LUMASIRAN SODIUM)

Patent Metadata

Patent number: AU2002347182A1
Jurisdiction: AU
Classification: —
Expires: 2003-06-30
Drug substance claim: No
Drug product claim: No
Assignee: Relief Therapeutics International SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.